Acurx Pharmaceuticals, Inc. Conversion of Stock, Shares Converted
Acurx Pharmaceuticals, Inc. (ACXP) had Conversion of Stock, Shares Converted of 14.08 million shares as of 2021-06-29, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow
us-gaap:ConversionOfStockSharesConverted1 · last filed 2023-11-13
- 2021-06-29: Conversion of Stock, Shares Converted 14.08M shares.
| Period end | Conversion of Stock, Shares Converted |
|---|---|
| 2021-06-29 | 14.08M shares 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B |